|
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News Archive - September 2023
Key HIV program jeopardized by U.S. budget wrangling, endangering millions
September 30, 2023 - GEOFFREY YORK - African activists are rushing to the defence of a multibillion-dollar U.S. health program, fearing that a surge of attacks by U.S. Republicans and anti-abortion groups will endanger its supply of life-saving medicine for millions of Africans with HIV.
Read more...
Where Have All the AIDS Walks Gone?
SEPTEMBER 29, 2023 - By Jason A. Michael - Pride Source - AIDS walks used to be a pivotal part of the fall community calendar, and now they’re virtually no more. Once upon a time, they were everywhere in Michigan — some nine across the state with two separate walks representing Detroit. They drew walkers by the thousands and raised substantial sums of money for local agencies working to combat the epidemic.
The first AIDS Walk Detroit (AWD) took place in 1991 in Royal Oak. It was a very grassroots effort put together by a handful of shopkeepers. AWD stood alone for a handful of years and grew quickly in size and scope. In 1999, along came AIDS Walk Michigan (AWM), an initiative to hold walks across the state under one umbrella. At its peak, AWM organized eight walks across the state, including Ann Arbor, Bay City/Saginaw/Midland, Detroit, Flint, Grand Rapids, Kalamazoo, Lansing and Traverse City.
Construction starts on affordable housing development in West End, QMUNITY's new home
Sep 29, 2023 - By Kate Walker - Construction started Friday on a 154-unit building set to house 2SLGBTQIA+ residents and people living with HIV/AIDS right in the heart of Davie Village in Vancouver’s West End.
Read more...
Canada and British Columbia support more affordable housing in Vancouver
Vancouver, British Columbia - September 29, 2023 - The governments of Canada and British Columbia along with the City of Vancouver announced combined funding of more than $91 million for a major affordable housing project that will build 154 new homes for people living and working in Vancouver.
The 17-storey building is located at 981 Davie Street, in the heart of Davie Village. The project will be a mixed-use development and will include 154 residential units and commercial space. The project will be designed to passive house standards for exceptional energy efficiency, using less heating and cooling energy than conventional buildings and reducing operating costs. It is also built with mass timber, which reduces carbon emissions and reduces the building's overall carbon footprint.
Global Fund Support for PrEP Ring Ushers in New Era for HIV Prevention in South Africa
GENEVA/JOHANNESBURG, 29 September 2023 - Three key organizations involved in preventing and responding to HIV in South Africa – AIDS Foundation of South Africa, Beyond Zero, and Networking HIV & AIDS Community of Southern Africa – have placed an initial order of 16,000 dapivirine vaginal rings for HIV prevention with the support of the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund).
The pre-exposure prophylaxis (PrEP) ring is a silicone ring that is inserted in the vagina every month and delivers long-acting, topical, and localized HIV prevention. To date, the dapivirine vaginal ring is the only PrEP ring approved by regulatory agencies for HIV prevention.
Study Finds Users Prefer Daily Oral PrEP Pill Despite New Options
September 28, 2023 - By Anna Zarra Aldrich - Drugs that prevent HIV infection have evolved, but new UConn research shows the standard option is still top with patients
When PrEP (pre-exposure prophylaxis), a drug that prevents HIV infection, was first approved by the FDA in 2012, it was a medical breakthrough that promised to drastically reduce HIV transmission. Traditionally, PrEP is administered via a pill that needs to be taken at the same time every day.
Now, there are even more delivery options. A new UConn study explores patient preference for the standard method and new options.
From HIV-AIDS to COVID-19, scholar Bishnupriya Ghosh unpacks decades of research to better understand the complexities of living with viruses
September 27, 2023 - Keith Hamm - As much of the world has come to know over the past three years, a viral pandemic can be as mysterious as it is detrimental. Its potential impact is a variable gestalt of dispassionate science, election-year politics and social and traditional media.
These interwoven complexities and many others fall under the scholarly command of Bishnupriya Ghosh, a professor of English and of global studies at UC Santa Barbara. Her latest book, “The Virus Touch: Theorizing Epidemic Media” (Duke University Press, 2023), explores relationships between viruses, humans, animals and the environment to show how various forms of media — from news content to lab test results — create our understanding of epidemics.
THE ELTON JOHN AIDS FOUNDATION AWARDS GRANT TO SAN ANTONIO AIDS FOUNDATION AND CORAZÓN SAN ANTONIO TO END NEW HIV INFECTIONS IN BEXAR COUNTY
SAN ANTONIO, Sept. 27, 2023 /PRNewswire/ -- - $500,000 Award from the Elton John AIDS Foundation Will Help Expand HIV and STI outreach, testing, prevention and linkage to care throughout San AntonioSan Antonio AIDS Foundation (SAAF) and Corazón San Antonio are excited to announce their newest community impact collaboration "SAAF Spaces with Corazón," in partnership with the Elton John AIDS Foundation. This two-year, $500,000 grant will help SAAF and Corazón San Antonio expand their services in HIV outreach, testing, prevention, and syringe exchange while providing resources to sex workers and people experiencing homelessness.
Global Integrase Inhibitors Market, 2023-2030: Efficacy and Safety of Integrase Inhibitors Make Them Key Players in HIV/AIDS Treatment
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) - The "Integrase Inhibitors Market, By Distribution Channel, By Region, By End User, and By Geography- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
Integrase inhibitors are vital medications used in the treatment of HIV/AIDS. They work by inhibiting the activity of the viral enzyme integrase, which is responsible for integrating the viral DNA into the host cell's DNA. This action prevents the virus from replicating and helps manage the infection.
National Gay Men’s HIV/AIDS Awareness Day 2023
September 27, 2023 - Gay and bisexual men account for 57% of the HIV population. New rates are declining among white and Black gay men, but not Latinos.
Wednesday, September 27, marks National Gay Men’s HIV/AIDS Awareness Day (#NGMHAAD) 2023. It’s an opportunity to call attention to the epidemic’s disproportionate impact on men who have sex with men—and to promote HIV prevention, testing and treatment among this population.
The awareness day was founded in 2008 by the now-defunct National Association for People with AIDS, writes HIV.gov, which also offers a series of downloadable graphics and posters.
Read more...
COULD THIS NEW HYDROGEL MAKE HIV THERAPY MORE CONVENIENT?
Septembeer 25, 2023 - By Roberto Molar Candanosa - A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, Johns Hopkins researchers have found
A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, researchers have found.
The gel releases a steady dose of the anti-HIV drug lamivudine over six weeks, suggesting people living with HIV could have new therapy that doesn't require a daily pill regimen to prevent AIDS.
Two champions for social justice to receive honorary degrees this fall
September 25, 2023 - By Bev Betkowski - An advocate who changed Canadian legal history and an early leader in HIV/AIDS research will receive the U of A’s highest honour during November convocation.
An outstanding legal advocate for human rights and a leader in compassionate medical care for people living with HIV/AIDS will receive the University of Alberta’s highest honour this November during fall convocation ceremonies.
Young people with sexual or gender diversity are at higher risk of stopping their HIV treatment because of stigma and harsh laws
September 24, 2023 - Ending the AIDS pandemic – particularly in eastern and southern Africa – cannot be achieved unless more resources are channelled to meet the needs of key vulnerable populations.
This is one of the themes that emerged during an AIDS conference in June in South Africa. Prejudice against particular groups – such as men who have sex with men (MSM) and transgender communities – interferes with treatment regimes and people’s adherence to treatment. These groups are also at higher risk from HIV due to increased levels of stigma, discrimination, violence and criminalisation.
Person named to HIV leadership role
Sep. 22, 2023 - by Paul Govern - Infectious diseases specialist Anna Person, MD, associate professor of Medicine, has been named to a four-year term as vice-chair of the board of the HIV Medicine Association (HIVMA).
Aligned with the Infectious Diseases Society of America, HIVMA, according to its website, “represents the interests of HIV health care providers and researchers and their patients by promoting quality in HIV care and advocating for policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice.”
Cinema Diverse 2023: “Commitment to Life” Documentary on Fight Against AIDS in Hollywood
September 22, 2023 - By Manny The Movie Guy - Jeffrey Schwarz’s “Commitment to Life” is a thorough and well-researched documentary that tells the true story of the fight against HIV/AIDS in Los Angeles and how a diverse group of people – doctors, movie stars, studio moguls, bar owners, activists – changed the course of the epidemic.
Read more...
The European AIDS Conference revisits Warsaw
22 September 2023 - Greta Hughson - Dr Esteban Martínez is president of the European AIDS Clinical Society (EACS) and a senior consultant in infectious diseases at Hospital Clínic in Barcelona, Spain. EACS organises the European AIDS Conference every two years. With the next conference taking place from 18 to 21 October, we spoke to Esteban about what to expect.
Read more...
Magic and Cookie Johnson Vow to Carry On Elizabeth Taylor’s Legacy As HIV/AIDS Activists: ‘This Is Where Our Heart Is’
Sep 22, 2023 - By Jaden Thompson, Caroline Brew - Magic Johnson is no less ambitious than he was when he was winning championships with the Los Angeles Lakers in the 1980s. Johnson is always seeking out new business ventures, having recently become part owner of the Washington Commanders and Los Angeles Dodgers. But amidst these new endeavors, Johnson’s dedication to HIV/AIDS advocacy has never wavered.
Read more...
Magic Johnson Praises Son EJ as a 'Beautiful Gay Man' as NBA Star Is Honored at End AIDS Gala
September 22, 2023 - By Anna Lazarus Caplan and Alex Cramer - The retired NBA superstar received the Elizabeth Taylor Commitment to End AIDS Award in Beverly Hills Thursday night
At the 4th annual Elizabeth Taylor Ball to End AIDS held at the Beverly Hills Hotel, Magic and his wife Cookie Johnson were presented with the Elizabeth Taylor Commitment to End AIDS Award, named for the late actress who used her platform to fight for awareness for the disease. Taylor and the Johnsons were very close and worked together as advocates before her death.
Read more...
A DAY WITH HIV
Get in the picture.
9/23/2023
On Saturday 23 September, take a photo of whatever your're doing. Use your smartphone or digital camera; it can be a smile, candid shot or artful image
A Day with HIV is a social media-driven campaign that portrays 24 hours in the lives of people all over the world affected by HIV—that’s all of us, regardless of status. On Saturday, September 23, photograph a moment of your day—it can be a selfie, an action photo or an artful image. Post the picture to your social media with the hashtag #adaywithhiv; add a caption that includes the TIME and LOCATION of your photo and what INSPIRED you to take it.
CAAN AND GILEAD SCIENCES CANADA IGNITE HOPE WITH NEW INDIGENOUS HEALTH GRANT
REGINA, SK, Sept. 21, 2023 /CNW/ - $4M investment aims to champion health equity for Indigenous communities
CAAN Communities, Alliances & Networks and Gilead Sciences Canada Inc. (Gilead Sciences Canada) today joined hands to unveil the GLOW Indigenous Health Grant: Guiding Local Opportunities for Wellbeing, a new $4M grant program supporting community organizations. The initiative will enable Indigenous-led solutions designed to address the unique needs of Indigenous Peoples in Canada affected by the human immunodeficiency virus (HIV) and viral hepatitis.
ECDC DIRECTOR: PROTECT PEOPLE’S HEALTH THIS AUTUMN THROUGH VACCINATION AND OTHER PREVENTIVE MEASURES
September 21, 2023 - ECDC - “Europe will soon see the arrival of autumn and winter, where we anticipate a resurgence of seasonal influenza and RSV. We are also seeing small increases in SARS-CoV-2 transmission in the EU/EEA and anticipate that all three viruses will co-circulate in the coming months. With this, there is the need to highlight the importance of vaccination and other public health measures to protect people’s health.
FACT SHEET: U.S. Action on Global Development
September 20, 2022 - In 2015, world leaders adopted the Sustainable Development Goals (SDGs) as a roadmap for improving lives and wellbeing of people around the world. At their core, the SDGs seek to expand economic opportunity, advance social justice, care for our planet, promote good governance, and ensure no one is left behind.
This week, the United States and leaders came together once again at the SDG Summit in New York to recommit to the 2030 Agenda for Sustainable Development and the SDGs. They met at a time of both challenge and tremendous opportunity around the world. They met with years of evidence that when countries come together under a common development vision – the SDGs and Millennium Development Goals before them – they have the capacity to deliver for both people and planet. For two decades, countries around the world delivered steady and extraordinary progress for millions of people to improve the quality of life and health outcomes of millions of people, while lowering poverty rates and slashing hunger from around the world.
Vir Biotechnology Announces First Participant Dosed in New Phase 1 Trial Evaluating VIR-1388, an Investigational T Cell Vaccine for the Prevention of HIV
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE )-- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the first participant has been dosed in a Phase 1 trial evaluating the safety, reactogenicity and immunogenicity of VIR-1388, an investigational novel T cell vaccine for the prevention of human immunodeficiency virus (HIV). The Company expects initial data from the Phase 1 trial in the second half of 2024.
VIR-1388 is based on the human cytomegalovirus (HCMV) vector platform and is designed to stimulate the body to produce immune cells known as T cells that recognize several HIV proteins in a way that differs from prior investigational HIV vaccines. VIR-1388 was developed using applied learnings from VIR-1111, the Company’s initial investigational proof-of-concept HIV T cell vaccine based on HCMV.
The path that ends AIDS by 2030 will boost progress towards achieving many other Sustainable Development Goals
NEW YORK/GENEVA, 20 September 2023 - UNAIDS, the Governments of Botswana and the United States of America, together with the European Commission have joined global partners to urge world leaders to get on the path that ends AIDS. This, they say, will also accelerate progress to reach many other of the Sustainable Development Goals.
The call was made at a high-level event, Celebrating Global HIV Progress to End AIDS and Advance the Sustainable Development Goals, held during the 78th United Nations General Assembly in New York. Participants underscored the life-saving impact of the global HIV response as well as the need for continued support, funding and commitment, including for the United States President's Emergency Plan for AIDS Relief (PEPFAR).
Unveiling Australia’s fastest next-gen mpox diagnostic tool
20 SEP 2023 - In response to the 2022 global outbreak of the monkeypox virus (MPXV), researchers have harnessed cutting-edge genetic technology to develop Australia’s first-of-its-kind tool for the detection of the virus.
In a collaborative study published in The Lancet Microbe, the team of scientists, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and WEHI (Walter and Eliza Hall Institute of Medical Research), revealed MPXV-CRISPR – a powerful diagnostic tool capable of detecting MPXV in clinical samples with acute precision and at a faster rate than any other method, thanks to the power of CRISPR technology. It is the first CRISPR-based diagnostic method in Australia specifically designed to target genetic sequences found only in MPXV.
Clinical trial of HIV vaccine begins in United States and South Africa
September 20, 2023 - Novel vaccine includes NIH-funded technology in development since 2004.
A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has provided scientific and financial support throughout the lifecycle of this HIV vaccine concept and is contributing funding for this study.
Emory researcher honored at White House for innovation in HIV treatment
Sept. 19, 2023 - Emory University researcher and inventor Dennis Liotta, PhD, has been named to the Bayh-Dole Coalition’s inaugural “Faces of American Innovation.” Liotta is among just five individuals to be recognized with the American Innovator Award by the Coalition, which consists of “a diverse group of innovation-oriented organizations and individuals committed to celebrating and protecting the Bayh-Dole Act.” Liotta was selected for “helping to transform HIV from a death sentence into a manageable illness.”
Angela Bassett & Courtney B. Vance to Host The Elizabeth Taylor Ball to End AIDS
September 19, 2023 -By: Michael Major - The upcoming Elizabeth Taylor Ball to End AIDS will be on September 21, 2023 at The Beverly Hills Hotel.
The Elizabeth Taylor AIDS Foundation (ETAF) TODAY announced award-winning actress, director, and executive producer Angela Bassett and award-winning actor Courtney B. Vance will host the upcoming Elizabeth Taylor Ball to End AIDS on September 21, 2023 at The Beverly Hills Hotel. The evening will be generously supported by Diamond Sponsor Bulgari, the Roman High Jeweler, whose creations were loved by Elizabeth.
Read more...
Targeting gut microbiome could be key to improving HIV health outcomes
September 19, 2023 - Tulane University researchers have been awarded a five-year, $3.6 million grant from the National Institutes of Health to study how changing the gut microbiome may ease chronic inflammation and associated gastrointestinal issues for people taking antiretroviral therapy (ART) for HIV.
Long-term ART is crucial for people living with HIV to maintain low viral levels and enjoy extended, healthy lives. However, it has been associated with chronic gut dysfunction and inflammation, contributing to the development of cardiovascular, metabolic, kidney, and liver diseases. The precise mechanism by which ART contributes to gut dysfunction and related diseases is not yet fully understood.
HUD Awards Nearly $30 Million to Local HIV/AIDS Housing Programs
WASHINGTON - September 19, 2023 - HUD Public Affairs - Funding offers stable housing for individuals and families at risk of homelessness.
The Office of HIV/AIDS Housing under the U.S. Department of Housing and Urban Development (HUD) has announced the allocation of $29,661,629 for Housing Opportunities for Persons With AIDS (HOPWA) Permanent Supportive Housing (PSH) Renewal and Replacement Grants. These grants assist with tenant-based rental assistance, supportive services, and other housing activities. The announcement is the first of two rounds of grants that will be made available.
Combining CAR T Cell Strategies to Achieve an HIV Cure
September 19, 2023 - By Jeffrey Laurence, M.D. - amfAR researchers re-engage with anti-HIV CAR T cell therapies by exploring new ways to enhance their activity
In their paper, amfAR grantee Dr. Martin Tolstrup and colleagues from Aarhus University, Denmark, review methods used in their laboratories, and those of others, to enhance the expansion and persistence of anti-HIV CAR T cells and also discuss novel strategies. These processes include genetic modification of CAR and the use of different starting materials—e.g., naïve and stem cell memory T cells, rather than the unselected bulk populations of T cells typical of CAR cancer treatments.
EUROPEAN COMMISSION AUTHORISES ViiV HEALTHCARE’S APRETUDE (CABOTEGRAVIR LONG-ACTING AND TABLETS) FOR HIV PREVENTION
London, 19 September 2023 - ViiV Healthcare - Given as few as six times per year, cabotegravir has demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition in clinical trials. -
- With approximately 100,000 people newly diagnosed with HIV each year in Europe, expanding HIV prevention options is crucial in reducing HIV transmission.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, welcomed a positive opinion by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorisation for cabotegravir long-acting (LA) injectable and tablets for HIV prevention. Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in high-risk adults and adolescents weighing at least 35 kg.
Climate Change and Conflict Slow Down Progress Despite Record Results
Geneva, Switzerland - September 18, 2023 - Results in the fight against HIV, TB and malaria exceed pre-COVID-19 numbers; yet colliding crises keep the world way off track to achieve 2030 targets
The Global Fund’s 2023 Results Report released shows a remarkable acceleration of programmatic results in the fight against HIV, TB and malaria, after losses from the COVID-19 pandemic. However, multiple challenges, including climate change and conflict, as well as deepening inequalities and growing threats to human rights, have put the target to end AIDS, TB and malaria by 2030 increasingly at risk.
Danish researchers take another big step toward HIV cure
18-SEP-2023 - AARHUS UNIVERSITY - A large international study may have brought us a step closer a cure for HIV. The key may lie in experimental medicine, which in two studies has been shown to enhance the immune system's own ability to suppress the virus
Today, HIV can be managed with medical treatment. However, despite 40 years of intensive research, scientists have not yet succeeded in finding a cure for the disease. People with HIV experience a flare-up of the virus only a few weeks after stopping treatment. But now, an international team of researchers, led by scientists at Aarhus University and Aarhus University Hospital, may have moved another step closer to a medication-free existence for the millions living with HIV today.
Ivy Phung works to build better vaccines
September 18, 2023 - Madeline McCurry-Schmidt - How a Ph.D. student found a place in the intense world of HIV vaccine research
Ivy Phung’s family knew she loved science from an early age. As a high schooler in the Bay Area, Phung got up early every day for a hands-on science elective class held during “zero period,” before the school day officially started. There she practiced wet lab skills, such as pipetting, that most students don’t get to learn until they get to college.
New York State Department of Health Recognizes National Hiv/Aids and Aging Awareness Day
ALBANY, N.Y. (September 18, 2023) - The AIDS Institute Continues to Prioritize Services to Promote the Health and Well-being of Adults 50+ Living with HIV
Department Launches People Aging with HIV Pilot Program Across State to Provide Comprehensive Health Related Supportive Services
The New York State Department of Health and the Department's AIDS Institute proudly join the nation today in honoring National HIV/AIDS and Aging Awareness Day, highlighting specific programming for People Aging with HIV, which helps to improve the health and well-being of New Yorkers over 50 years of age living with HIV.
"Advances in health care treatment have changed the trajectory of HIV from a deadly disease for many to a manageable chronic illness for most," State Health Commissioner Dr. James McDonald said. "There is still work to be done as we face new infections among older adults and challenges for those over age 50 living with HIV, but today, we pause to celebrate the courage and perseverance of all those who are aging with HIV/AIDS."
It's Time to Pay Attention to Older Americans Living With HIV, Advocates Say
SEPTEMBER 18 2023 - By Trudy Ring - In observance of National HIV/AIDS and Aging Awareness Day, here's a look at some of the issues this population faces.
There was a time when the terms “HIV” and “aging” didn’t go together at all. Now, as effective treatments give people living with HIV a normal life expectancy, those terms do — but aging with HIV raises its own set of issues.
With Monday marking National HIV/AIDS and Aging Awareness Day, activists are drawing attention to some of those issues. Some HIV specialists lack knowledge about the health consequences of aging, and specialists in aging often aren’t well-versed regarding HIV. Medical providers sometimes aren’t aware of how HIV drugs interact with those prescribed for diseases that come with age.
Read more...
National HIV/AIDS and Aging Awareness Day 2023
September 18, 2023 - By Trent Straube - People 55 and older represent 41% of the U.S. population living with HIV. Learn more about #HIVandAging and #NHAAD.
The 2023 U.S. Conference on HIV/AIDS (USCHA) ended September 9 in Washington, DC. But nearly a week later, many of us 4,000 attendees are still unpacking, literally and figuratively. Spearheaded by NMAC and held in a different city each year, the HIV conference is an epic, immersive experience spanning five days (and nights) loaded with education, entertainment, inspiration and emotion. It’s a lot.
Read more...
8th annual Positively Aging Project to feature HIV/AIDS activist Peter Staley
Sept 18, 2023 - By Ema Sasic - Palm Springs Desert Sun - The conference, with a theme of "Mind, Body, Soul," will feature experts in HIV research discussing living and aging with HIV, and panels on staying fit and medical cannabis. This year's keynote speaker is Peter Staley, who was a member of the grassroots political group ACT UP (AIDS Coalition to Unleash Power) New York, and later became the founding director of TAG (Treatment Action Group).
The Positively Aging Project, organized by HIV+ Aging Research Project Palm Springs, will be held from 9 a.m. to 3:30 p.m. Saturday, Sept. 23 both in person at the Mizell Center in Palm Springs and virtually on Zoom.
Read more...
Another class of cancer drugs may contribute to curing HIV
18 September 2023 - Gus Cairns - Two drugs from a class new to HIV medicine called BH3 mimetics were unveiled at July’s 12th IAS Conference on HIV Science in Brisbane. They may contribute to a cure for HIV by killing off long-lived cells that contain HIV genes in their DNA. Notably, venetoclax (Venclexta) and obatoclax only killed off cells containing intact DNA, capable of giving rise to new viruses, and did not delete cells containing defective, harmless DNA.
Read more...
Reps. Johnson, Velázquez and B. Lee Introduce Resolution Federally Recognizing National African Immigrant and Refugee HIV/AIDS and Hepatitis Awareness (NAIRHHA) Day
WASHINGTON, D.C. - September 18, 2023 - NAIRHHA Day, September 9th, has been recognized in HIV/AIDS and Hepatitis communities but will now be recognized federally for the first time.
Today, Hepatitis Caucus Co-Chairs, Congressman Hank Johnson and Congresswoman Nydia Velázquez (NY) along with HIV/AIDS Caucus Co-Chair, Congresswoman Barbara Lee (CA), introduced a resolution to recognize September 9th as National African Immigrant and Refugee HIV/AIDS and Hepatitis Awareness (NAIRHHA) Day.
NAIRHHA Day takes place in September because this is the month that has been designated as National African Immigrant Month in the United States, to celebrate the diverse and remarkable contributions African immigrants have made to enrich the United States, in spheres ranging from sports to writing to politics. Recognition of NAIRHHA Day is a matter of health equity and will assist with resolving one of the most pronounced health disparities affecting African immigrant communities today.
Inside the battle to open Insite 20 years ago, and why it never ended
Sep 15, 2023 - Lori Culbert - Insite was Canada's first supervised injection site. Its 2003 opening was a harm reduction victory but didn't lead to badly needed solutions to save lives.
Longtime drug-user Dean Wilson was one of many advocates who fought to open North America’s first supervised injection site in Vancouver 20 years ago. They were an eclectic group that included former drug-users, community activists, a conservative mayor and middle-class parents of addicted children.
Read...
Report: Europe far from reaching global HIV targets
September 15, 2023 - Europe still has a long road ahead in its fight against HIV, according to a new report by the European Centre for Disease Prevention and Control (ECDC), which identifies key targets such as prevention, testing, and ending discrimination.
The United Nations Global AIDS Strategy aims to end AIDS as a public health threat by 2030 with all countries reaching a 95% target compliance rate by 2025, to ensure they are on track.
The first local case of mpox caused by an imported case in the Chinese mainland
15-SEP-2023 - Monkeypox (mpox) is a zoonotic disease caused by the mpox virus (MPXV) that has been primarily limited to Central and West African nations since its discovery. The recent spread of the West African lineage of MPXV in historically unaffected countries has raised concerns for global public health. Despite a significant decrease in global mpox cases, there is still a risk of a global resurgence. This study reports the first local case of mpox caused by an imported case in the Chinese mainland.
Syphilis transmission networks and antimicrobial resistance in England uncovered using genomics
Unique new UL-led research finds bacteria resistant to antibiotics in hospital wastewater system
15-SEP-2023 - Wellcome Sanger Institute - Scientists use genomics to uncover syphilis transmission patterns in England, in a pioneering new approach for STI surveillance.
Scientists have used genomics to reveal distinct sexual networks for syphilis transmission, defined geographically or by sexual preference, among a background of wider circulation in England. They also show a presence of drug resistance in the majority of cases.
Unique new UL-led research finds bacteria resistant to antibiotics in hospital wastewater system
September 15, 2023 - A unique new study led by researchers at University of Limerick has found that bacteria that may lead to hospital acquired infection is present in a hospital’s wastewater system.
In a partnership with University Hospital Limerick and Queen’s University Belfast, the UL School of Medicine has completed an extensive and unique study that saw researchers dive deep into hospital wastewater to find a reservoir of bacteria resistant to antibiotics.
Do you know your HIV status? You can now test yourself at home
September 15, 2023 - By Victoria Idowu - Global News - Knowing your HIV status just got easier with the launch of the free HIV self-test kit.
The kit is distributed through Canadian AIDS Treatment Information Exchange (CATIE ), Canada’s source for HIV and hepatitis C information.
Read more...
Highlights From the 2023 U.S. Conference on HIV/AIDS
September 15, 2023 - By Trent Straube - #2023USCHA was a Love Letter to Black Women—and a joyous family reunion for the HIV community. [VIDEOS]
The 2023 U.S. Conference on HIV/AIDS (USCHA) ended September 9 in Washington, DC. But nearly a week later, many of us 4,000 attendees are still unpacking, literally and figuratively. Spearheaded by NMAC and held in a different city each year, the HIV conference is an epic, immersive experience spanning five days (and nights) loaded with education, entertainment, inspiration and emotion. It’s a lot.
Read more...
Europe and Central Asia Falling Short on UNAIDS Targets for Ending AIDS by 2030
September 15, 2023 - ECDC - As the number of new HIV infections and AIDS-related mortality rates continue to fall in Europe and Central Asia, according to a ECDC recent report, progress towards ending the AIDS epidemic by 2030 is variable across the region, and most countries in Europe and Central Asia are currently far from achieving the 2025 targets.
Only 83% of all people living with HIV know their status, 85% of people who know their status are being treated, and 93% of people on treatment are virally suppressed. This means the region is not on track to meet the 2025 targets set by UNAIDS, which are 95% for each of the mentioned targets. ECDC data show that testing and treatment services need to be scaled up, and countries should consider implementing and expanding innovative testing interventions, such as community and self-testing services.
Long-Acting PrEP Solutions for At-Risk Populations
September 14, 2023 - By Carl Dimitri - A new study from Brown researchers examines more effective medication adherence strategies for PrEP among men who have sex with men in the U.S.
For HIV prevention, a daily pill known as pre-exposure prophylaxis, or PrEP, is a lifeline for high-risk populations. However, staying faithful to this daily regimen isn’t always straightforward, and lapses can compromise its effectiveness.
There are many reasons people don't stick with PrEP, including cost, disruption to daily routines, HIV-related stigma, and fear of real and perceived side effects of the medication.
Resources for 2023 National HIV/AIDS and Aging Awareness Day
September 14, 2023 - HIV/gov - From the National HIV/AIDS Strategy (NHAS) and an upcoming U.S. Department of Housing and Urban Development (HUD) to the Office of Infectious Disease and HIV/AIDS Policy (OIDP) Aging Challenge, we encourage you to learn more about National HIV/AIDS and Aging Awareness Day (NHAAD). Led by the AIDS Institute, NHAAD is observed each year on September 18th to focus on the increasing number of people living long, full lives with HIV. The awareness day also calls attention to the unique health and social needs, as well as the challenges of HIV prevention, testing, treatment, and care in older adults.
HIV.gov FYI - HIV & Aging
Sep 14, 2023 - Research will identify improved treatment regimens in understudied patient population
During #2023USCHA, HIV.gov talks with the White House's Harold Phillips, Director of the Office of National AIDS Prevention about HIV and Aging.
Studies on Mobile Health Intervention Suggest Positive Impact for Black Same Gender–Loving Men
September 13, 2023 - Rutgers - The mobile application, iTHRIVE 365, is the first of its kind to provide psychological health resources, connections to economic support and a safe social space created by and for Black gay, bisexual and other same gender–loving men.
iTHRIVE 365, a mobile health application developed through a collaboration between the Rutgers School of Public Health, THRIVE Social Services (THRIVE SS), Positive Impact Health Centers Georgia and CorporateLounge, a digital development company, creates a space to access HIV/AIDS and psychological health information, community support and resources for culturally affirming health care, housing and other forms of economic support among Black same gender loving men.
2023 Harvard Chan School Alumni Awards announced
September 13, 2023 - Harvard T.H. Chan School of Public Health - The Harvard T.H. Chan School of Public Health Alumni Association recently announced the recipients of the 2023 Alumni Awards, who were chosen by their peers through a nomination and voting process. Below are excerpts from the biographies of the winners. The awards will be presented during this year’s Alumni Weekend, which takes place September 28-30.
“Dormant” HIV produces RNA and proteins during anti-retroviral therapy
13 Sep 2023) - Cell Press - HIV anti-retroviral therapy is considered a treatment and not a cure because patients usually carry a reservoir of HIV-infected cells that can re-emerge if treatment stops. These reservoirs have long been thought to be dormant, but two independent groups of researchers report in the journal Cell Host & Microbe on September 13th that a subset of these cells spontaneously produce HIV RNA and proteins that may impact patients’ HIV-specific immune responses.
Opinion George W. Bush: Michael Gerson’s words make the case for saving PEPFAR
September 13, 2023 - By George W. Bush - We are on the verge of ending the HIV/AIDS epidemic. To abandon our commitment now would forfeit two decades of unimaginable progress and raise further questions about the worth of America’s word.
The reauthorization is stalled because of questions about whether PEPFAR’s implementation under the current administration is sufficiently pro-life. But there is no program more pro-life than one which has saved more than 25 million lives. I urge Congress to reauthorize PEPFAR for another five years without delay.
Read more...
Women With HIV May Have Higher Comorbidity Burden Than Men
September 13, 2023 - By Liz Highleyman - Studies underline the need for better prevention and management of age-related health problems.
Women living with HIV are more likely to have other age-related conditions that can affect their overall health and quality of life, according to study results published in JAMA Network Open. What’s more, another study found that the protective effect of female sex against heart disease was diminished for HIV-positive women.
Read more...
Sheryl Lee Ralph to be Honored With Project Angel Food’s Inaugural Legacy Award at 2023 Angel Awards
September 13, 2023 - By BreAnna Bell - VARIETY - AIDS activist Mary Fisher will receive the 2023 Angel Award at the Sept. 23 ceremony.
Sheryl Lee Ralph will receive Project Angel Food’s Inaugural Sheryl Lee Ralph Legacy Award at this year’s Angel Awards on Sept. 23 in Hollywood.
Read more...
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
12 September 2023, Geneva/New York - TB is curable but remains the world’s leading infectious disease killer
Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Nations (UN) in New York, to endorse ambitious commitments to ramp up TB testing, treatment and prevention in light of innovative medical tools that have become available over the last decade but that still do not reach hundreds of thousands of people who need them – in large part because of corporations’ monopolies. Médecins Sans Frontières/Doctors Without Borders (MSF) strongly called on US corporations Johnson & Johnson (J&J) and Cepheid to publicly announce by the High-Level Meeting on 22 September that they will take action to improve access to the lifesaving TB drug bedaquiline and GeneXpert tests, respectively, so these can be made available for everyone who needs them, everywhere. MSF calls on J&J not to enforce any ‘secondary’ patents for bedaquiline in any country with a high burden of TB, and to withdraw and abandon all pending secondary patent applications for this critical drug everywhere. MSF also calls on Cepheid, and its parent corporation Danaher, to drop the price of the GeneXpert TB tests from US$15 and $10, to $5.*
HIV Cure Research: An Update
BC-Cfe Webinar Learning Series Event
Wednesday, September 27, 2023, 12:00 pm - 1:00 pm
This webinar will be presented by:
Zabrina Brumme, Ph.D Lab Director, BC Centre for Excellence in HIV/AIDS Professor, Faculty of Health Sciences, Simon Fraser University.
Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.
Mount Sinai Gets $3.4M to Probe Prostate Cancer in HIV Patients
New York, NY (September 12, 2023) - Mount Sinai - Research will identify improved treatment regimens in understudied patient population
The National Cancer Institute has awarded the Icahn School of Medicine at Mount Sinai a $3.4 million grant to create a model that identifies the best prostate cancer treatment for people with HIV.
This project will use state-of-the-art computer models and data to investigate the natural progression of prostate cancer, and outcomes using various treatments, in people with HIV to identify treatment approaches that work best in this vulnerable group.
Roughly 1% of gay, bisexual men in Portugal had mpox during 2022 outbreak
September 12, 2023 - Mary Van Beusekom, MS, - CIDRAP - A genomic and epidemiologic analysis of data from the 2022 mpox outbreak estimates that 1.3% of men who have sex with men (MSM) in Portugal were infected.
HARP, Sault museum team up to raise funds for HIV/AIDS Memorial
September 12, 2023 - 'Wear your best red' at the Positively Red Ball set for the Grand Gardens on Oct. 13
To help in the fight against HIV/AIDS, the Group Health Centre’s HIV and AIDS Resource Program (HARP) has teamed up with the Sault Ste. Marie Museum to bring the community the Positively Red Ball.
The ball is an age 19+ event that will take place on Friday, Oct. 13 at the Grand Gardens, beginning at 7:30 p.m.
Listen or Read...
END HIV STIGMA: Advocates Deliver Facts on the Fight Against HIV to the U.S. Conference on HIV/AIDS
September 12, 2023 - By GLAAD - The GLAAD Media Institute’s Tristan Marra, Vice President Research & Reports, DaShawn Usher, Director, Communities of Color, and Julian J. Walker, Associate Director Communities of Color, were on the ground for the 27th Annual United States Conference on HIV/AIDS in Washington DC on September 8th to present the latest findings from GLAAD’s 2023 State of HIV Stigma Report.
Read more...
Illinois HIV Care Connect’s Health Beyond HIV Campaign Offers Advice to Avoid or Manage Chronic Medical Conditions
SPRINGFIELD, Ill.--(BUSINESS WIRE)--September 12, 2023 - Illinois HIV Care Connect today introduces its Health Beyond HIV Campaign. Through website and social media content, the campaign will feature information that can help persons living with HIV to avoid or manage chronic medical conditions, known as co-morbidities.
According to the National Institutes of Health, persons living with HIV are at elevated risk for developing chronic health conditions such as cardiovascular disease, cancer, diabetes mellitus, and chronic kidney disease. These individuals are also at elevated risk for developing coinfections such as hepatitis B, hepatitis C, and tuberculosis.
7 AIDS Activists Arrested at Kevin McCarthy's Office Protesting PEPFAR Delay
September 12, 2023 - By Trudy Ring - Republicans in Congress are delaying reauthorization of the HIV prevention and treatment program because of abortion politics.
Activists protested Monday at Speaker of the House Kevin McCarthy’s office in Washington, D.C., over the delay in reauthorizing a program to fight HIV and AIDS in the U.S. and sub-Saharan Africa, and seven were arrested.
Demonstrators from Housing Works and Health GAP chanted “Pass PEPFAR now, McCarthy!,” referring to the President’s Emergency Plan for AIDS Relief, which started in 2003 under President George W. Bush.
Read more...
Human Rights Campaign Foundation Kicks Off Two Leadership Programs Combating HIV Stigma and Health Disparities
WASHINGTON - September 11, 2023 - Human Rights Campaign (HRC) Foundation -Today, the Human Rights Campaign (HRC) Foundation, the educational arm of the nation’s largest lesbian, gay, bisexual, transgender, and queer (LGBTQ+) civil rights organization, through the leadership of its HIV & Health Equity program, launched of two critical programs that will work to engage LGBTQ+ Black and Latiné young people in the mission to address health inequities and end the HIV epidemic by providing mentorship, resources and education to help them become effective changemakers in their communities.
HIV: two autopsies reveal where the virus hides
09/11/2023 - By BRUNO GEOFFROY - A Canadian research team shows for the first time that HIV reservoirs are concentrated in the spleen and lymph nodes, and that they can travel throughout the body.
A small number of HIV-infected cells remain in the tissues of people living with the virus and who are undergoing antiretroviral therapy. These viral reservoirs, real obstacles to the cure of HIV, have long been known to exist.
Until now, however, it wasn't known which organs the virus prefers to hide in.
A team from the Canadian HIV Cure Enterprise (CanCure) led by Université de Montréal immunology professor Nicolas Chomont, a researcher at the CHUM Research Centre (CRCHUM), has succeeded in identifying these hidden places, opening the way to targeting them for future therapies.
For ‘Silver Tsunami’ With H.I.V., New Hope for Healthy Aging
Sept. 10, 2023 - By Benjamin Ryan - A recent study showed that a statin drug significantly lowered the risk of heart attacks and strokes among middle-aged and older people with the virus.
Americans with H.I.V. are achieving the once unthinkable: a steady march into older age. But beginning around age 50, many people living with the virus face a host of health problems, from heart disease and diabetes to social isolation and cognitive decline.
Read more...
Rep. Maxine Waters condemns House Republicans seeking HIV/AIDS program cuts
Sep 10, 2023 - Ashlee Banks
- They don't seem to care whether or not people will die if they don't have the medicines that are needed,” said Rep. Maxine Waters, D - CA
House Republicans have threatened to cut funding to national and global HIV/Aids programs, prompting Rep. Maxine Waters, a longtime Democrat from California, to condemn the move, saying it will have a detrimental impact Black communities.
Read more...
‘HIV cases to more than double by 2030’
MANILA, Philippines - September. 10, 2023 - Rhodina Villanueva - The Philippine Star - The number of Filipinos living with human immunodeficiency virus (HIV) will more than double by 2030, according to an official of the Department Health (DOH).
“The projected increase in new HIV infections is 36,700 in 2030 from 26,700 this year,” Noel Palaypayon of the National HIV and STI Surveillance and Strategic Information unit of the DOH’s Epidemiology Bureau said during an HIV summit held on Friday.
Read more...
Republican opposition to abortion threatens global HIV/AIDS program that has saved 25 million lives
NAIROBI, Kenya (AP) - Sep 09, 2023 - The graves at the edge of the orphanage tell a story of despair. The rough planks in the cracked earth are painted with the names of children, most of them dead in the 1990s. That was before the HIV drugs arrived.
Today, the orphanage in Kenya’s capital is a happier, more hopeful place for children with HIV. But a political fight taking place in the United States is threatening the program that helps to keep them and millions of others around the world alive.
Read more...
Diving legend Greg Louganis to auction off medals to help HIV center
September 9, 2023 -CBS 8 San Diego - Hidden in the history of San Diego sports is diving legend Greg Louganis. Many consider Louganis to be the greatest diver in the history of the sport. He grew up in El Cajon and attended Valhalla High School before going on to win 5 Olympic medals and 5 World Championships.
Olympian Greg Louganis: We Need to Improve Care for Older People Living with HIV
September 9, 2023 - Olympic Gold Medalist Greg Louganis is working to raise awareness of mental health challenges people face and how to overcome them.
Greg Louganis says that in order to navigate the stresses of daily life, you have to find your rhythm.
He’s an icon of the Olympic diving board with four gold medals to his name, an LGBTQ+ activist, an HIV awareness and mental health advocate, as well as an actor. In order to stay centered and calm through it all, it goes back to something very simple — just breathing in and out.
Read more...
SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV
September 8, 2023 - Population Counci l- Manufacturing Master Service Agreement signed to further development of a non-antiretroviral on-demand HIV prevention product.
SwiftPharma, a Belgium-based manufacturer, and the Population Council, a global nonprofit research organization, have signed a Manufacturing Master Service Agreement for the plant-based manufacture of Griffithsin to further the Council’s development of a Griffithsin fast-dissolving vaginal insert for protection against HIV.
The Population Council has been developing a non-antiretroviral HIV-prevention method containing Griffithsin (GRFT) in a fast-dissolving insert (FDI). This Griffithsin FDI is an on-demand, user-controlled, portable prevention technology in early development that is designed to be manufacturable in low- and middle-income countries.
BRITISH SEX LIVES REVEALED IN NEW STUDY
8th Sep 2023 - University of East Anglia - A new study published today shows the number of sexual partners we have changes as we age – and there are some surprising results.
Researchers from the University of East Anglia (UEA), in collaboration with King’s College London and University College London, surveyed more than 5,000 people aged 18 years and older during the 2022 mpox (previously known as “monkeypox”) outbreak.
The team wanted to better understand how sexual behaviours change with age, so that mathematical models of sexually transmitted infections can be made more accurate. Key findings included in the paper, published today in the journal PLOS ONE, show that many gay and bisexual men over age 70 continue to have a sex life with multiple partners, while straight women become less sexually active after age 50.
HIV and Hepatitis C Care: Focusing on Innovations
September 8, 2023 - by Amy Anderson - A team of researchers across Yale School of Medicine (YSM) and The University of Texas Health Science Center at San Antonio (UTHSCSA) has published a set of papers on innovations in patient care for those diagnosed with hepatitis C (HCV), who are also living with human immunodeficiency virus (HIV).
The papers were published as part of a special edition entitled, “Innovations in HIV/HCV Care,” in Health Promotion Practice (HPP), the peer-reviewed journal of the Society for Public Health Education (SOPHE) on September 6, 2023.
Anemia afflicts nearly 1 in 4 people worldwide, but there are practical strategies for reducing it
September 8, 2023 - Anemia is a major health problem, with nearly 2 billion people affected globally. It afflicts more people worldwide than low back pain or diabetes – or even anxiety and depression combined.
Despite this, investments in reducing anemia have failed to substantially reduce the massive burden of anemia globally over the last few decades.
Government of Canada Improves Access to Sexual and Reproductive Health
September 7, 2023 - Edmonton, Alberta - Health Canada - Everyone, regardless of their sexual or gender identity, should have access to sexual and reproductive health (SRH) services and resources that are safe and stigma-free. However, experiences of discrimination within Canada’s health care system have and continue to make it more difficult for many members of marginalized groups to get the care they need. This is especially true for 2SLGBTQI+, Indigenous, Black and racialized communities, as well as women and youth, as the barriers they face are also compounded by a lack of culturally safe, relevant, equitable and stigma-free information and services.
Cruel Irony: People Living With HIV Now Face Chronic Disease
GENEVA, Sept 7 - A new report advocates integrating non-communicable diseases (NCD) in the HIV response, as people living with HIV are living longer; it’s a cruel irony of the success of the HIV response that they now face higher NCD prevalence than adults without HIV.
Integrating non-communicable disease (NCD) health services for people living with HIV delivers significant returns on investment and better health outcomes for patients, according to a new report.
The report titled “Spending Wisely: Exploring the Economic and Societal Benefits of Integrating HIV/AIDS and NCDs Service Delivery” was launched today ahead of the Global Week for Action on NCDs by the Geneva-based NCD Alliance and non-profit institute RTI International.
Antibodies that ‘wait and pounce’ generated by promising HIV vaccine candidate
7 September 2023 - Gus Cairns - An HIV vaccine candidate has proved it can guide B-cells, the part of the immune system that makes antibodies, into being able to produce broadly neutralising antibodies (bnAbs) with the ability to block the entry into T-cells of many strains of HIV. Dr Wilton Williams of Duke University described the vaccine candidate in a plenary talk at July’s 12th International AIDS Society Conference on HIV Science (IAS 2023).
Read more...
Uganda's NDA found HIV drugs in meat but didn't issue warning
Sept 7, 2023 - By Dorcas Wangira - BBC News - Uganda's National Drug Authority has admitted it knew HIV medicine was being used to fatten up animals in 2014 but did not warn the public.
The regulator's senior drugs inspector Amos Atumanya told parliament it became aware anti-retrovirals were being given to pigs and chickens to treat them.
Read more...
#2023USCHA: Day 1 Recap
Sep 7, 2023 - HIV.gov - The 2023 U.S. Conference on HIV/AIDS (#2023USCHA) opened Wednesday, 9/6, in Washington DC. Watch for highlights from opening day.
Epidemiological update: COVID-19 transmission in the EU/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023
September 7, 2023 - ECDC - A new study has been published in The Lancet Global Health showing that almost 1 in 3 men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and 1 in 5 are infected with one or more of what are known as high risk, or oncogenic, HPV types. These estimates show that men frequently harbour genital HPV infections and emphasize the importance of incorporating men in efforts to control HPV infection and reduce the incidence of HPV related disease in both men and women.
Maxine Waters criticizes House Republicans over proposed cuts to HIV/AIDS programs
September 6, 2023 - By Michael K. Lavers - Calif. Democrat spoke at U.S. Conference on HIV/AIDS in D.C.
U.S. Rep. Maxine Waters (D-Calif.) on Wednesday sharply criticized House Republicans over their proposed cuts to HIV/AIDS prevention programs.
The California Democrat who represents the state’s 43rd Congressional District in a speech she delivered at the U.S. Conference on HIV/AIDS in D.C. noted the House Appropriations Committee’s Fiscal Year 2024 Labor, Health, Human Services, Education and Related Agencies Appropriations Bill would cut $767 million from domestic HIV/AIDS programs.
Read more...
First-Ever National Initiative Addressing the Health of Black Cisgender and Transgender Women with HIV Releases Site-Specific Outcomes
Lowell, MA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Twelve sites nationwide leveraged bundled interventions—novel, integrated, community-informed approaches to delivering health services—for Black cisgender and transgender women with HIV
The Black Women First (BWF) initiative, administered by the Health Resources and Services Administration (HRSA), Ryan White HIV/AIDS Program (RWHAP), Special Projects of National Significance (SPNS) with funding from the Minority HIV/AIDS Fund, recently wrapped up three years of implementing and evaluating bundled evidence-informed and evidence-based interventions at 12 sites nationwide. The initiative marked the first-ever national project dedicated to improving the health outcomes of Black cisgender and transgender women with HIV. Led by the University of Massachusetts Lowell (UMass Lowell), with evaluation support from the Boston University Center for Innovation in Social Work and Health (CISWH) and implementation expertise and technical assistance from AIDS United, sites demonstrated bundled interventions featuring multi-pronged strategies to engage and retain Black women with HIV into treatment and care. These strategies included:
International Humanitarian Organization Unveils New Flagship Office
Chicago, Ill. (Sept. 6, 2023) - Zakat Foundation of America - Zakat Foundation of America, an international NGO, is thrilled to announce a new flagship office located in Houston, Texas, located at 3949 Braxton Ave.
A formal presentation and inauguration of the Houston office will take place Saturday, Sept. 9, at 6:00 p.m. at the Hyatt Regency Houston West Hotel (13210 Katy Freeway, Houston, TX).
The Global Number of New HIV Infections Is Falling
Sep 6, 2023 - by Anna Fleck - There were an estimated 1.3 million new HIV infections in 2022, according to UNAIDS newly published report. While still too high, this figure is the lowest in decades, with declines particularly strong in regions with the highest HIV burdens.
As the following chart shows, Eastern and southern Africa have seen a fall of 57 percent of new HIV infections between 2010 and 2022. However, the region still has the highest number of new cases annually, with 500,000 recorded new infections in 2022. Asia and the Pacific had the second highest number of new cases at 300,000 worldwide, yet also saw a substantial fall, this time of -14 percent, over the 12 year period.
Beauty salon–based intervention increases trust of PrEP among Black cisgender women
September 6, 2023 - by Wolters Kluwer Health: Lippincott - Stigma about PrEP and consideration of using it also improved somewhat
Among African American and other Black cisgender women, a beauty salon–based intervention improved knowledge and awareness of pre-exposure prophylaxis (PrEP) against HIV and increased trust in it, according to a pilot study published in the September issue of The Journal of the Association of Nurses in AIDS Care (JANAC) the official journal of the Association of Nurses in AIDS Care. JANAC is published in the Lippincott portfolio by Wolters Kluwer.
Gene Linked to HIV Viral Load in People of African Ancestry
Sep 6, 2023 - By Olivia Dmimer - Naturally occurring variations near the human gene CHD1L may be linked to lower HIV-1 viral load in people of African ancestry, according to a new international, multicenter study published in Nature.
Globally, 39 million people were living with HIV at the end of 2022, according to estimates from the World Health Organization (WHO). Countries in Africa continue to experience a higher rate of HIV disease burden, with more than two-thirds of new HIV infections occurring in African countries, according to WHO data.
Medical cannabis use in Australian patients with chronic health issues linked to significant improvements in overall health-related quality of life and fatigue levels
September 6, 2023 - Cannabis therapy also linked to improvements in anxiety, depression, and pain levels—though no changes in sleep disturbance levels reported
Australian patients with chronic health issues prescribed medical cannabis showed significant improvements in overall health-related quality of life and fatigue in the first three months of use, along with improvements in anxiety, depression, and pain. Interestingly, cannabis therapy did not seem to improve reported sleep disturbances, according to a study published September 6, 2023 in the open-access journal PLOS ONE by Margaret-Ann Tait from the University of Sydney, Australia, and colleagues.
Global research on HIV prevention to be transformed thanks to £5 million award
5 September 2023 - Researchers from seven international institutions hope to transform traditional strategies used to tackle global HIV prevention for key populations particularly affected by the virus, thanks to a new £5 million Wellcome Discovery award to Professor Peter Vickerman at the University of Bristol.
Despite efforts to eliminate HIV, levels remain high among key populations, with UNAIDS estimating that globally men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW) have three to 11 times higher burden of HIV infection and contribute to the majority of new HIV infections. The £5 million award will fund an eight-year study to improve current prevention strategies for these key populations.
Viatris Announces U.S. FDA Tentative Approval of a Paediatric Formulation of Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC), a Once-daily Treatment for Children Living with HIV
PITTSBURGH and BANGALORE, India, Sept. 5, 2023 /PRNewswire/ -- Tentative approval will help enhance access to WHO-recommended paediatric regimen with the goal of improved adherence of HIV treatment for children in low- and middle-income countries
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced U.S. Food and Drug Administration (FDA) tentative approval for a New Drug Application for abacavir 60 mg/dolutegravir 5 mg/lamivudine 30 mg tablets for oral suspension for the treatment of HIV-1 infection in paediatric patients.
The World Health Organization (WHO) recommends abacavir/dolutegravir/lamivudine as a preferred first-line regimen for paediatric patients. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), treatment coverage for children and adolescents lags behind adults. Some 660,000 children living with HIV – about 43 percent of the estimated total 1.5 million [1.2 million–2.1 million] children living with HIV – did not receive antiretroviral (ARV) therapy in 2022. Accordingly, children accounted for 13 per cent of AIDS-related deaths in 2022, even though they comprise only about 4 percent of people living with HIV.
Longtime Ally Rep. Maxine Waters is Keynote Speaker at Major HIV/AIDS Conference in Washington D.C.
Washington D.C. - September 5, 2023 - Rep. Maxine Waters - Congresswoman Waters is the keynote speaker at this year's United States Conference on HIV/AIDS in Washington D.C.
Congresswoman Maxine Waters (D-CA), Ranking Member of the House Financial Services Committee, has been a leading advocate for HIV/AIDS awareness and funding for decades. Before coming to the U.S. Congress in 1991, she worked with community leaders to raise funding for local minority HIV/AIDS initiatives in Los Angeles and introduced legislation in the California State Assembly that would address the epidemic's disproportionate impact on African Americans. As a Member of the U.S. Congress, she spearheaded the establishment of the Minority AIDS Initiative (MAI) to build the capacity of minority-led organizations that are culturally competent and understand their own communities.
No deal in sight for global AIDS program as deadline looms
09/05/2023 - By ALICE MIRANDA OLLSTEIN and CARMEN PAUN - The law governing the President’s Emergency Plan for AIDS Relief will lapse on Oct. 1.
Congress is almost certain to blow past a Sept. 30 deadline to re-up the law governing the United States’ global HIV/AIDS relief work as the widely praised program becomes mired in the fight over abortion.
Read more...
New study shows effectiveness of mpox vaccine
5 September 2023 - Queen Mary University of London - The research, published in The Lancet Infectious Diseases, was delivered by the SHARE-net collaborative and looked at 38 mpox infections in 37 gay and bisexual men. Eight of the 38 were reinfections, and 30 infections occurred after a complete vaccination course. In the people who had been vaccinated, the results showed that the patients had fewer lesions (abnormal tissue such as a wound or rash), less mucosal disease (diseases of the mucous membranes of the mouth and genitals), and a minimal need for pain medication or hospitalisation.
Long-Term Survivors and Youth Benefit From U=U
September 5, 2023 - By Charles Sanchez - Gregg Cassin and Hernando Umana credit Undetectable Equals Untransmittable with helping them live fuller lives with HIV.
An HIV survivor for almost 30 years, Gregg Cassin, 65, started his spiritual journey as a boy growing up on Long Island, New York. “As a kid, it was not in the days of Ellen [DeGeneres],” he said, “there were no openly gay people. I had no idea who I was or what I was.” Since there were no role models for him in his life, Cassin did what he calls “the Catholic boy thing.”
Read more...
The Global POC HIV Testing Market is forecasted to grow by USD 290.77 mn during 2022-2027, accelerating at a CAGR of 2.91% during the forecast period
New York, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Global POC HIV Testing Market 2023-2027. The POC HIV testing market is forecasted to grow by USD 290.77 mn during 2022-2027, accelerating at a CAGR of 2.91% during the forecast period.
Reportlinker.com announces the release of the report "Global POC HIV Testing Market 2023-2027." The report on the POC HIV testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of HIV aids worldwide, rapid growth in outsourcing of laboratory testing services, and the advantages of POC HIV testing.
Defending Health: Rising Prevalence of Infectious Diseases Drives Global Anti-Infective Agents Market Growth to 2028
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Anti-Infective Agents Market (2023-2028) by Type, Drug Class, Route of Administration, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Anti-Infective Agents Market is estimated to be USD 226.84 Bn in 2023 and is expected to reach USD 307.89 Bn by 2028, growing at a CAGR of 6.3%.
One in three men worldwide are infected with genital human papillomavirus
1 September - World Health Organization - A new study has been published in The Lancet Global Health showing that almost 1 in 3 men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and 1 in 5 are infected with one or more of what are known as high risk, or oncogenic, HPV types. These estimates show that men frequently harbour genital HPV infections and emphasize the importance of incorporating men in efforts to control HPV infection and reduce the incidence of HPV related disease in both men and women.
Rady grad student profile: Erwin Taguiam studies gene expression in tuberculosis and HIV co-infection
SEPTEMBER 1, 2023 - People living with HIV are at high risk for tuberculosis (TB).
In fact, in 2021, TB was the leading cause of death worldwide among people diagnosed with HIV.
“Studies have shown that HIV and tuberculosis reinforce each other,” says Erwin Taguiam, a 25-year-old master’s student in medical microbiology and infectious diseases at the Max Rady College of Medicine.
|
